These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Correlation between peritoneal mesothelial cell cytology and peritoneal histopathology with respect to prognosis in patients on continuous ambulatory peritoneal dialysis. Izumotani T; Ishimura E; Yamamoto T; Otoshi T; Okuno S; Inaba M; Kim M; Nishizawa Y Nephron; 2001 Sep; 89(1):43-9. PubMed ID: 11528231 [TBL] [Abstract][Full Text] [Related]
27. Double bag or Y-set versus standard transfer systems for continuous ambulatory peritoneal dialysis in end-stage renal disease. Daly C; Campbell M; Cody J; Grant A; Donaldson C; Vale L; Lawrence P; MacLeod A; Wallace S; Khan I Cochrane Database Syst Rev; 2001; (2):CD003078. PubMed ID: 11406068 [TBL] [Abstract][Full Text] [Related]
28. Immunologic patterns in CAPD patients with peritonitis. Lamperi S; Carozzi S Clin Nephrol; 1988; 30 Suppl 1():S41-4. PubMed ID: 3052960 [TBL] [Abstract][Full Text] [Related]
29. [Effect of intraperitoneal administration of sandoglobulin on peritoneal fluid IgG level in patients treated by standard peritoneal dialysis (SPD)]. Wańkowicz Z; Panasiuk-Jarzyło E; Pietrzak B; Szczylik C; Raczka A; Kłos M Pol Arch Med Wewn; 1992 Jan; 87(1):14-20. PubMed ID: 1641361 [TBL] [Abstract][Full Text] [Related]
30. Multiple-dose-kinetics of ofloxacin after intraperitoneal application in CAPD patients. Kampf D; Borner K; Hain H; Conrad W Perit Dial Int; 1991; 11(4):317-21. PubMed ID: 1751596 [TBL] [Abstract][Full Text] [Related]
31. Specific opsonic activity for staphylococci in peritoneal dialysis effluent during continuous ambulatory peritoneal dialysis. Nielsen H; Espersen F; Kharazmi A; Antonsen S; Ejlersen E; Joffe P; Pedersen FB Am J Kidney Dis; 1992 Oct; 20(4):372-5. PubMed ID: 1415206 [TBL] [Abstract][Full Text] [Related]
33. Continuous ambulatory peritoneal dialysis- a new dimension in the treatment of end-stage renal disease. Shohat J; Boner G; Rosenfeld J; Waller A; Iaina A; Eliahou HE Isr J Med Sci; 1982 Oct; 18(10):1014-8. PubMed ID: 7174268 [TBL] [Abstract][Full Text] [Related]
34. Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory peritoneal dialysis in a Mexican PD center. Sanchez AR; Madonia C; Rascon-Pacheco RA Kidney Int Suppl; 2008 Apr; (108):S76-80. PubMed ID: 18379553 [TBL] [Abstract][Full Text] [Related]
35. Peritonitis prevention in continuous ambulatory peritoneal dialysis. Luzar MA Nephrologie; 1992; 13(4):171-7. PubMed ID: 1407258 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of 300 mg/d Intraperitoneal Daptomycin: New Insight from the DaptoDP Study. Saint Paul LP; Ficheux M; Debruyne D; Loilier M; Bouvier N; Morello R; Verdon R; Le Blanc E; Cattoir V; Lobbedez T Perit Dial Int; 2018; 38(6):463-466. PubMed ID: 30413641 [TBL] [Abstract][Full Text] [Related]
37. Recovery of gastrointestinal function after renal transplantation in a patient with sclerosing peritonitis secondary to continuous ambulatory peritoneal dialysis. Hawley CM; Wall DR; Johnson DW; Campbell SB; Griffin AD; Rigby RJ; Petrie JJ Am J Kidney Dis; 1995 Oct; 26(4):658-61. PubMed ID: 7573023 [TBL] [Abstract][Full Text] [Related]
38. Staph aureus peritonitis in patients on continuous ambulatory peritoneal dialysis. Kim D; Tapson J; Wu G; Khanna R; Vas SI; Oreopoulos DG Trans Am Soc Artif Intern Organs; 1984; 30():494-7. PubMed ID: 6533929 [No Abstract] [Full Text] [Related]